Search

everythinglearnresearchcommunity

for

Search:↓

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

AS101 reduces hair loss from chemotherapy.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Scalp cryotherapy significantly reduces hair loss during and shortly after chemotherapy.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Thorough evaluations and conservative management can lead to positive outcomes in pediatric adrenocortical carcinoma.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

ALRN-6924 may prevent hair loss caused by chemotherapy.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Anti-cancer drugs are diverse and hard to classify due to their different forms and actions.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.